Pathophysiology of cutaneous lupus erythematosus

被引:0
作者
Jordan C Achtman
Victoria P Werth
机构
[1] Philadelphia VA Medical Center,Department of Dermatology
[2] Perelman Center for Advanced Medicine,undefined
来源
Arthritis Research & Therapy | / 17卷
关键词
Systemic Lupus Erythematosus; Hyaluronic Acid; Systemic Lupus Erythematosus Patient; Cutaneous Lupus Erythematosus; Discoid Lupus Erythematosus;
D O I
暂无
中图分类号
学科分类号
摘要
The pathophysiology of cutaneous lupus erythematosus (CLE) encompasses the complex interactions between genetics, the environment, and cells and their products. Recent data have provided enhanced understanding of these interactions and the mechanism by which they cause disease. A number of candidate genes have been identified which increase the risk of developing CLE. Ultraviolet radiation, the predominant environmental exposure associated with CLE, appears to initiate CLE lesion formation by inducing apoptosis, precipitating autoantigen presentation, and promoting cellular production of specific cytokines. Autoantibodies are a well-known entity in CLE, but their exact role remains unclear. Finally, cells ranging from native skin cells to innate and adaptive immune cells produce cytokines and other molecules and play specific roles in lesion formation and perpetuation. Native skin cells implicated in CLE include keratinocytes and endothelial cells. Innate immune cells crucial to CLE pathophysiology include dendritic cells and neutrophils. The primary adaptive immune cells thought to be involved include Th1 cells, Th17 cells, cytotoxic T cells, and invariant natural killer T cells. Though the pathophysiology of CLE has yet to be fully characterized, current research provides direction for future research and therapies.
引用
收藏
相关论文
共 341 条
[1]  
Yu C(2013)Immunologic and genetic considerations of cutaneous lupus erythematosus: a comprehensive review J Autoimmun. 41 34-45
[2]  
Chang C(1994)Association between chronic cutaneous lupus-erythematosus and HLA class-II alleles Hum Immunol. 41 280-284
[3]  
Zhang J(2004)Genetic background of cutaneous forms of lupus erythematosus: update on current evidence J Appl Genet. 45 77-86
[4]  
Fischer GF(2013)MHC class II polymorphisms, autoreactive T-cells, and autoimmunity Front Immunol. 4 321-58
[5]  
Pickl WF(2001)Ultraviolet-radiation-induced keratinocyte apoptosis in C1q-deficient mice J Invest Dermatol. 117 52-61
[6]  
Fae I(1979)Hereditary C2-deficiency associated with cutaneous lupus-erythematosus - clinical, laboratory, and genetic studies Arch Dermatol. 115 57-897
[7]  
Anegg B(1983)Partial genetic deficiency of the C-4 component of complement in discoid lupus-erythematosus and urticaria angioedema J Am Acad Dermatol. 9 894-730
[8]  
Milota S(2000)Association of a promoter polymorphism of tumor necrosis factor-alpha with subacute cutaneous lupus erythematosus and distinct photoregulation of transcription J Invest Dermatol. 115 726-106
[9]  
Volcplatzer B(2007)Pathophysiology of cutaneous lupus erythematosus Clin Rev Allergy Immunol. 33 85-131
[10]  
Osmola A(2010)Tyrosine kinase 2 and interferon regulatory factor 5 polymorphisms are associated with discoid and subacute cutaneous lupus erythematosus Exp Dermatol. 19 123-737